LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1

Historical Institutional Holders from Q2 2019 to Q3 2023

All holders as of September 30, 2023
Q3 2023
Type / Class
Debt / NOTE 0.750% 5/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2023 Q3 $0 $0 -$299K 0
2023 Q2 $300K $299K -$66.1M $1.00 1
2023 Q1 $66.8M $66.4M +$5.27M $0.99 25
2022 Q4 $61.6M $60.1M +$1.1M $0.97 24
2022 Q3 $60.5M $58.8M -$38.2M $0.97 22
2022 Q2 $99.7M $96.5M -$63.9M $0.96 23
2022 Q1 $163M $160M -$147M $0.98 30
2021 Q4 $308M $309M -$3.64M $1.00 32
2021 Q3 $322M $324M -$848K $1.00 38
2021 Q2 $323M $320M -$15.2M $0.99 43
2021 Q1 $336M $349M -$134M $1.04 48
2020 Q4 $475M $451M -$23.1M $0.95 46
2020 Q3 $505M $458M +$27.5M $0.91 47
2020 Q2 $480M $424M -$14.9M $0.88 47
2020 Q1 $500M $419M -$192M $0.83 44
2019 Q4 $735M $637M -$20.7M $0.87 48
2019 Q3 $744M $622M +$15.2M $0.83 47
2019 Q2 $726M $627M +$621M $0.86 49